de la Cueva, Ignacio Salamanca
Gerber, Jennifer E.
Hastie, Andrew
Brotons, Carlos
Panzer, Falko
Pirçon, Jean-Yves
Talsma, Paul
Eckermann, Tamara
Nikic, Vanja
Gomez, Xavier Martinez
Alsdurf, Hannah
Funding for this research was provided by:
GlaxoSmithKline Biologicals S.A funded this study
Article History
Accepted: 4 June 2024
First Online: 29 June 2024
Declarations
:
: GlaxoSmithKline Biologicals S.A funded this study (GlaxoSmithKline [GSK] study identifier: 213829) and was involved in all stages of the study, including analysis of the data. GlaxoSmithKline Biologicals S.A also funded all costs associated with the development and publishing of the manuscript.
: Carlos Brotons, Ignacio Salamanca, Tamara Eckermann, and Falko Panzer declare that their institution received payment from GSK for the conduct of the study. Xavier Martínez‐Gómez declares having received payment or honoraria for lectures, presentations, meetings, or educational events from AstraZeneca and Pfizer. Andrew Hastie, Jean-Yves Pirçon, Jennifer E. Gerber, Vanja Nikic, and Hannah Alsdurf were employees of the GSK group of companies. Andrew Hastie, Jean-Yves Pirçon, and Vanja Nikic possesses stock options in GSK. Paul Talsma was an employee of the GSK group of companies at the time of the study. The authors declare no other financial and non‐financial relationships and activities.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committees and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The following ethics committees, institutional review boards, and regulatory authorities were consulted in line with country requirements: Comitté d’Etique hospitalo-facultaire Erasme - Université Libre de Bruxelles in Belgium (approval received: 15 September, 2022), Ethik-Kommission der Bayerischen Landesärztekammer in Germany (approval received: 12 September, 2022), Landesärztekammer Baden-Württemberg Körperschaft des Öffentlichen Rechts Ethik-Kommission in Germany (approval received: 2 November, 2022), Comité de Ética de la Investigación Biomédica de Andalucía in Spain (approval received: 4 July, 2022), and Generalitat de Catalunya in Spain (approval received: 25 September, 2022).
: Not applicable.
: Written informed consent or assent was obtained from all individual participants included in this study or their parent(s), guardian(s), or legally acceptable representative(s) prior to participation in the study.
: Anonymized individual participant data and study documents can be requested for further research from .
: Not applicable.
: All authors participated in the design, implementation, analysis, and interpretation of the study and the development of this manuscript. All authors had full access to the data and approved the final manuscript prior to submission.
: AlphaRix Tetra, Influsplit Tetra, and Fluarix Tetra are trademarks owned by or licensed to the GSK group of companies.